Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 459
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 112
Clinical Trials 107
Central Nervous System Drugs 105
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 95
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 35
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
HIV/AIDS Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

2,422 Results (Page 10 of 122)
- Relevance
  Sort by

Biopharmaceuticals Market by Product Type, Therapeutic Area, Route Of Administration, Technology, Distribution Channel, End User, Pricing Model - Global Forecast to 2030

 Report
May 2025
197 Pages
Global

From

€3174EUR$3,545USD£2,763GBP

€3527EUR$3,939USD£3,070GBP

Kidney Cancer Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4020EUR$4,490USD£3,499GBP

Bladder Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
230 Pages
Global

From

€2686EUR$3,000USD£2,338GBP

Kidney Cancer Diagnostics and Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4020EUR$4,490USD£3,499GBP

Epidural Abscess Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4020EUR$4,490USD£3,499GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Non-Small Cell Lung Cancer Market by Type, Treatment Type, Distribution Channel, and Geography: Forecast up to 2027

 Report
July 2023
223 Pages
Global

From

€4029EUR$4,500USD£3,507GBP

Lung Cancer Therapeutics Market 2025-2029

 Report
February 2025
216 Pages
Global

From

€2239EUR$2,500USD£1,948GBP

Lung Cancer Drugs Market by Therapeutic Class, Cancer Type, Line of Therapy, Molecule Type, Route of Administration, Distribution Channel, End User - Global Forecast to 2030

 Report
May 2025
192 Pages
Global

From

€3174EUR$3,545USD£2,763GBP

€3527EUR$3,939USD£3,070GBP

Lung Cancer Therapeutics Market by Therapy Type, Line of Therapy, Type of Lung Cancer, Mode of Administration, Distribution Channel - Global Forecast to 2030

 Report
May 2025
198 Pages
Global

From

€3174EUR$3,545USD£2,763GBP

€3527EUR$3,939USD£3,070GBP

Non-small Cell Lung Cancer Therapeutics Market by Treatment Type, Line of Therapy, Biomarker Expression, Distribution Channel - Global Forecast to 2030

 Report
May 2025
194 Pages
Global

From

€3174EUR$3,545USD£2,763GBP

€3527EUR$3,939USD£3,070GBP

Kidney Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
185 Pages
Global

From

€4029EUR$4,500USD£3,507GBP

NASH Treatment & Therapeutics Market Report 2023-2033

 Report
July 2023
224 Pages
Global

From

€4697EUR$5,429USD£3,950GBP

Immune Checkpoint Inhibitors for Lung Cancer Market by Cancer Type, Distribution Channel, Treatment Regimen, End User, Mechanism of Action, Line of Therapy - Global Forecast to 2030

 Report
May 2025
184 Pages
Global

From

€3174EUR$3,545USD£2,763GBP

€3527EUR$3,939USD£3,070GBP

Extensive Stage Small Cell Lung Cancer Market by Treatment Type, Distribution Channel, End User, Mode Of Administration - Global Forecast to 2030

 Report
May 2025
198 Pages
Global

From

€3174EUR$3,545USD£2,763GBP

€3527EUR$3,939USD£3,070GBP

Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)

 Report
February 2022
84 Pages
Global

From

€1163EUR$1,299USD£1,012GBP

Ovarian Cancer Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4020EUR$4,490USD£3,499GBP

Melanoma Therapeutics Market Size, Share & Trends Analysis Report By Product (Chemotherapy, Immunotherapy), By Drug Type (Branded Drugs, Generic Drugs), By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
100 Pages
Global

From

€5328EUR$5,950USD£4,637GBP

Lupus Nephritis Treatment Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€4449EUR$4,969USD£3,872GBP

Metastatic Renal Cell Carcinoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
170 Pages
Global

From

€2239EUR$2,500USD£1,948GBP

Renal Cell Carcinoma: Global Drug Forecast and Market Analysis to 2028

 Report
February 2020
160 Pages
Global

From

€13427EUR$14,995USD£11,686GBP

2,422 Results (Page 10 of 122)
- 1
- 8
- 9
- 10
- 11
- 12

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.